Boston Scientific
1,057 hedge funds and large institutions have $70.6B invested in Boston Scientific in 2023 Q3 according to their latest regulatory filings, with 99 funds opening new positions, 441 increasing their positions, 351 reducing their positions, and 94 closing their positions.
26% more repeat investments, than reductions
Existing positions increased: 441 | Existing positions reduced: 351
5% more first-time investments, than exits
New positions opened: 99 | Existing positions closed: 94
0.78% more ownership
Funds ownership: 90.53% → 91.31% (+0.78%)
1% less funds holding
Funds holding: 1,066 → 1,057 (-9)
1% less capital invested
Capital invested by funds: $71.5B → $70.6B (-$961M)
3% less funds holding in top 10
Funds holding in top 10: 30 → 29 (-1)
18% less call options, than puts
Call options by funds: $426M | Put options by funds: $520M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$422M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$299M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$154M |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$147M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$137M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$429M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$346M |
| 3 |
Neuberger Berman Group
New York
|
-$166M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$135M |
| 5 |
Two Sigma Advisers
New York
|
-$124M |
BSX Hedge Fund Activity: Q3 2023 in Review
1,057 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q3 2023, worth a combined $70.6B — down 1.3% from $71.5B a quarter earlier.
Buyers outnumbered sellers: 99 funds opened new BSX positions and 94 closed out — a net gain of 5 holders — while 441 added to existing stakes and 351 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $422M. The largest seller was BlackRock, cutting an estimated $429M.
- 1,057 institutional investors held Boston Scientific (BSX) as of Q3 2023, down from 1,066 in Q2 2023.
- Funds reported $70.6B of Boston Scientific stock for Q3 2023, down 1.3% quarter-over-quarter.
- 99 funds opened new Boston Scientific positions in Q3 2023 and 94 closed out, a net change of +5 holders.
- The largest Boston Scientific buyer in Q3 2023 was Fidelity Investments, an estimated $422M added.
- The largest Boston Scientific seller in Q3 2023 was BlackRock, an estimated $429M sold.
Based on aggregated 13F filings for Q3 2023.